Answer
The selected tablets are not recommended for paediatric use, and safety and efficacy of the selected intravenous product have not been established in children.
Sources for this answer
- Hydralazine 25 mg Tablets / Apresoline 25 mg Tablets — Current selected SmPCemc · Summary of Product Characteristics
- Hydralazine 20mg Powder for Concentrate for Solution for Injection/Infusion — Current selected SmPCemc · Summary of Product Characteristics